Uncategorized

Merck and Sarah Cannon team up to boost oncology trial efficiency

Published

on

Oncology R&D organization Sarah Cannon Research Institute (SCRI) announced a collaboration with Merck & Co. to increase patient access to oncology trials at community-based sites in the U.S.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version